Determination of bat lyssavirus in Slovenia
Abstract
Background: To study bats, as a reservoir for European bat lyssavirus (EBLV) in Slovenia, native bat samples were tested in year 2008. Bats were captured from diff erent locations in Slovenia and blood samples, mouth and brain swabs were collected from live and dead bats. 260 samples of oral swabs and 38 brain samples were tested by specifi c RT-PCR assay to detect lyssavirus genome. Results: 216 blood samples, collected from the same bats, were tested by FAVN (Fluorescent Antibody Virus Neutralization) test to detect the prevalence of lyssavirus antibodies among bats. Virus RNA was not detected in any of the samples, all blood samples werealso negative for specifi c antibodies. Conclusions: Despite the data from this study, EBL viruses can cause fatal infections in humans and all bats involved in contact incidents with humans should be tested to determine whether the victim was exposed to EBL virus. In order to prevent lyssavirus transmission from bats to humans, all bat handlers and laboratory personnel should be informed about the possible risk of lyssavirus exposure via bats and their vaccination against rabies is strongly recommended .Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
